dihexa administration method metabolically stabilized stability ph degradation pathways Evaluation of Angiotensin IV Analogs as Procognitive/Antidementia Agents Optimization and Degradation Studies on – dihexa injection vs oral Follow – Dihexa | | 1401708-83-5 |

Conclusion This case highlights the diagnostic complexity of pernicious anemia, particularly when overlapping nonspecific symptoms and comorbidities, such as fibromyalgia, hypothyroidism, and autoimmune diseases, obscure the clinical picture and delay recognition

In addition, the applicability of these findings to older adults, patients with multimorbidity, or those with long-standing disease remains uncertain

Bloodwork and lab panels to establish baseline biomarkers (hormone levels, metabolic profile, liver/kidney function, etc.)

Detection in athletic testing can result in anti-doping violations

Gastrointestinal applications warrant symptom diaries, quality of life measures, and endoscopic assessment when indicated